JOHN ROCKWOOD: Open Payments
NPI 1548274558 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$485 in 19 payments from 11 companies in 2025. Trend: 2023 $631 · 2024 $815 · 2025 $485
Food & beverage: $485
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 2 | $140 |
| ABBVIE INC. | 4 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| Axsome Therapeutics, Inc. | 3 | $59 |
| Alkermes, Inc. | 1 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Indivior Inc. | 1 | $14 |
Products named: BRIXADI, VRAYLAR, REXULTI, Auvelity, VIVITROL, CAPLYTA, ABILIFY ASIMTUFII, UZEDY.
Industry payments across OH — which companies pay providers there.
